European Experience and Perspectives on Transcatheter Aortic Valve Replacement

Progress in Cardiovascular Diseases

Volumn 56, Issue 6, 2014, Pages 625-634

  Davies, William R ^a   Thomas, Martyn R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Aortic stenosis; European; High risk; Review; TAVI

Indexed keywords

AORTA VALVE STENOSIS; ARTICLE; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; EUROPE; GOVERNMENT REGULATION; HEALTH SURVEY; HEART VALVE BIOPROSTHESIS; HISTORY OF MEDICINE; HUMAN; NONHUMAN; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; REIMBURSEMENT; RISK MANAGEMENT; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC STENOSIS; EUROPEAN; HIGH RISK; REVIEW; TAVI;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COST-BENEFIT ANALYSIS; EUROPE; HEALTH CARE COSTS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84900026734     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.02.002     Document Type: Article

References (46)

1. Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis 2012, 105:146-152.
2. Letac B., Cribier A., Koning R., et al. Results of percutaneous transluminal valvuloplasty in 218 adults with valvular aortic stenosis. Am J Cardiol 1988, 62:598-605.
3. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation 1991, 84:2383-2397.
4. Davies H. Catheter-mounted valve for temporary relief of aortic insufficiency. Lancet 1965, 285:250.
5. Moulopoulos S.D., Anthopoulos L., Stamatelopoulos S., et al. Catheter-mounted aortic valves. Ann Thorac Surg 1971, 11:423-430.
6. Phillips S.J., Ciborski M., Freed P.S., et al. A temporary cathetertip aortic valve: hemodynamic effects on experimental acute aortic insufficiency. Ann Thorac Surg 1976, 21:134-137.
7. Andersen H.R., Knudsen L.L., Hasenkam J.M. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992, 13:704-708.
8. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002, 106:3006-3008.
9. Cribier A., Eltchaninoff H., Tron C., et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004, 43:698-703.
10. Cribier A., Eltchaninoff H., Tron C., et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: midterm follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006, 47:1214-1223.
11. Grube E., Laborde J.C., Zickmann B., et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv Dec 2005, 66(4):465-469.
12. Grube E., Schuler G., Buellesfeld L., et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007, 50:69-76.
13. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. EHJ 2003, 24:1231-1243.
14. Iung B., Valhanian A. Degenerative calcific aortic stenosis: a natural history. Heart 2012, 98:iv7-iv13.
15. Vahanian A., Alfieri O., Al-Attar N., et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention 2008, 4:193-199.
16. Transcatheter Aortic Valve Implantation (TAVI) A position statement of the British Cardiovascular Intervention Society (BCIS) and the Society of Cardiothoracic Surgeons (SCTS) [Accessed 20th August 2013]. http://www.bcis.org.uk/resources/documents/BCIS%20SCTS%20position%20statement.pdf.
17. Naber C.K., Prendergast B., Thomas M., et al. An interdisciplinary debate initiated by the European Society of Cardiology Working Group on valvular heart disease. Eurointervention 2012, 7:1257-1274.
18. Généreux P., Head S.J., Wood D.A., et al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J 2012, 33(19):2388-2398.
19. Thomas M., Schymik G., Walther T., et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010, 122:62-69.
20. Thomas M., Schymik G., Walther T., et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011, 124:425-433.
21. Kappetein A.P., Head S.J., Généreux P., et al. Valve Academic Research Consortium (VARC)-2. Eur J Cardiothorac Surg Nov 2012, 42(5):S45-S60.
22. Mylotte D., Osnabrugge R.L.J., Windecker S., et al. Transcatheter aortic valve replacement in Europe. Adoption trends and factors influencing device utilization. JACC 2013, 62(3):210-219.
23. Sedaghat A., Sinning J.M., Vasa-Nicotera M., et al. The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol Nov 2013, 10(11):821-829.
24. Piazza N., Wenaweser P., van Gameren M., et al. Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons predicted risk of mortality score in patients implanted with the CoreValve ReValving system-a Bern-Rotterdam Study. Am Heart J Feb 2010, 159(2):323-329.
25. Van Mieghem N.M., Serruys P.W. The art of risk stratification in TAVI. Eur Heart J Jul 2013, 34(25):1859-1861.
26. Gotzmann M., Pljakic A., Bojara W., et al. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response. Am Heart J Aug 2011, 162(2):238-245.
27. Lange R., Bleiziffer S., Elhmidi Y., et al. Transcatheter aortic valve implantation: the European experience. J Thorac Cardiovasc Surg Mar 2013, 145(3 Suppl.):S17-S21.
28. National Institute for Health and Clinical Excellence NICE interventional procedure guidance 421. Transcatheter aortic valve implantation for aortic stenosis Issued: March 2012 [accessed August 2013]. http://www.nice.org.uk/nicemedia/live/11914/58611/58611.pdf.
29. Fairburn T.A., Meads D.M., Hulme C., et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart 2013, 99:914-920.
30. Chevreul K., Brunn M., Cadier B., et al. Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Arch Cardiovasc Dis 2013, 106:209-219.
31. Prendergast B.D., Naber C.K., Popma J.J. Transatlantic perspectives on TAVI: from essential infrastructure and integration to expansion, research and development. Heart 2012, 98(Suppl. 4):iv37-iv43.
32. Bekeredjian R., Krumsdorf U., Chorianopoulos E., et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80years of age. Am J Cardiol 2010, 106(12):1777-1781. [15].
33. Ussia G.P., Barbanti M., Cammalleri V., et al. Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis. Eurointervention 2011, 7(5):573-579.
34. Van Brabandt H., Neyt M., Hulstaert Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ Jul 31 2012, 345:e4710.
35. Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012, 33:2451-2496.
36. Iung B. Management of the elderly patient with aortic stenosis. Heart 2008, 94:519-524.
37. Lefevre T., Kappetein A.P., Wolner E., et al. PARTNER EU Investigator Group. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011, 32:148-157.
38. Eltchaninoff H., Prat A., Gilard M., et al. FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011, 32:191-197.
39. Himbert D., Descoutures F., Al-Attar N., et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 2009, 54:303-311.
40. Bosmans J.M., Kefer J., De Bruyne B., et al. Belgian TAVI Registry Participants. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg 2011, 12:762-767.
41. Walther T., Falk V., Kempfert J., et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg 2008, 33:983-988.
42. D'Onofrio A., Salizzoni S., Agrifoglio M., et al. Medium term outcomes of transapical aortic valve implantation: results from the Italian registry of trans-apical aortic valve implantation. Ann Thorac Surg Sep 2013, 96(3):830-836.
43. Tamburino C., Capodanno D., Ramondo A., et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011, 123:299-308.
44. Piazza N., Grube E., Gerckens U., et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. Eurointervention 2008, 4:242-249.
45. Petronio A.S., De Carlo M., Bedogni F., et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010, 3:359-366.
46. Zahn R., Gerckens U., Grube E., et al. German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011, 32:198-204.